Skip to content

Author

Britney N. Lizama

We have 1 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Multi-omics comparative analyses of synucleinopathy models reveal distinct drug targets and relevance for drug development

The set of disrupted proteins/genes were compared to that aberrantly expressed in human PD and dementia with Lewy bodies and candidate drug targets in a “PD drug development pipeline”, revealing potential disease biomarkers and optimal models for testing novel therapeutics.

Britney N. Lizama, Rick Shin, Hilary A. North et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.